Administration of a High-Dose Erythropoietin-Stimulating Agent in Hemodialysis Patients is Associated with Late Arteriovenous Fistula Failure

PURPOSE: Investigating the risk of vascular access failure is critical for maintenance hemodialysis (MHD) patients. Erythropoietin stimulating agents (ESA) typically used for anemia of chronic kidney disease (CKD) may also stimulate neointimal hyperplasia, which is the most important factor in late...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hye Yun, Ko, Eun-Jung, Kim, Sang Hoon, Lee, Mi Jung, Cho, Hye Jeong, Yang, Dong Ho, Lee, So-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447111/
https://www.ncbi.nlm.nih.gov/pubmed/28540993
http://dx.doi.org/10.3349/ymj.2017.58.4.793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447111/
https://www.ncbi.nlm.nih.gov/pubmed/28540993
http://dx.doi.org/10.3349/ymj.2017.58.4.793

Ejemplares similares